Oral anticoagulation self management and management by a specialist anticoagulation clinic: A randomised cross-over comparison

Lancet

Volumn 356, Issue 9224, 2000, Pages 97-102

  Cromheecke, Manon E ^a   Levi, Marcel ^a   Colly, Louisa P ^b   De Mol, Bas J M ^a   Prins, Martin H ^a   Hutten, Barbara A ^a   Mak, Rachel ^a   Keyzers, Katinka C J ^a   Büller, Harry R ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Amsterdam Thrombosis Service (LPC)   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K;

ADULT; ANTICOAGULATION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; HUMAN; INTERNATIONAL STANDARD UNIT; MALE; MEDICAL SPECIALIST; NETHERLANDS; PATIENT SATISFACTION; PRIORITY JOURNAL; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL; SELF CARE; THROMBOEMBOLISM; TIME;

EID: 0034622382     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)02470-3     Document Type: Article

References (35)

1. Hirsh J. Oral anticoagulant drugs. N Engl J Med. 324:1991;1865-1875.
2. Hirsh J., Dalen J.E., Anderson D.R.et al. Oral anticoagulants. mechanism of action, clinical effectiveness, and optimal therapeutic range Chest. 114:1998;445S-469S.
3. O'Reilly R.A., Aggeler P.M. Determinants of the response to oral anticoagulant drugs in man. Pharmacol Rev. 22:1970;35-96.
4. Fairweather R.B., Ansell J., van den Besselaar A.M.et al. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of oral anticoagulant therapy. Arch Pathol Lab Med. 122:1998;768-781.
5. Cortelazzo S., Finazzi G., Viero P.et al. Thrombotic and hemorrhagic complications in patients with mechanical heart valve prosthesis attending an anticoagulation clinic. Thromb Haemost. 69:1993;316-320.
6. Errichetti A.M., Holden A., Ansell J. Management of oral anticoagulant therapy. Experience with an anticoagulation clinic. Arch Intern Med. 144:1984;1966-1968.
7. van der Meer J., Hillege H.L., Kootstra G.J.et al. Prevention of one-year vein-graft occlusion after aortocoronary-bypass surgery: a comparison of low-dose aspirin, low-dose aspirin plus dipyridamole, and oral anticoagulants. The CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands. Lancet. 342:1993;257-264.
8. Effect of long-term oral anticoagulant treatment on mortality and cardiovascular morbidity after myocardial infarction. Anticoagulants in the Secondary Prevention of Events in Coronary Thrombosis (ASPECT) Research Group. Lancet. 343:1994;499-503.
9. Cannegieter S.C., Rosendaal F.R., Wintzen A.R., van der Meer F.L., Vandenbroucke J.P., Briet E. Optimal oral anticoagulant therapy in patients with mechanical heart values. N Engl J Med. 333:1995;11-17.
10. Poller L., Shiach C.R., MacCallum K.et al. Multicentre randomised study of computerised anticoagulant dosage. European Concerted Action on Anticoagulation Lancet. 352:1998;1505-1509.
11. Leaning K.E., Ansell J.E. Advances in the monitoring of oral anticoagulation. point-of-care testing, patient self-monitoring , and patient self-management J Thromb Thrombolys. 3:1996;377-383.
12. Tripodi A., Chantarangkul V., Clerici M., Negri B., Mannucci P.M. Determination of the international sensitivity index of a new near-patient testing device to monitor oral anticoagulant therapy. Thromb Haemost. 78:1997;855-858.
13. Kitchen S., Preston F.E. Monitoring oral anticoagulant treatment with the TAS near-patient test system. comparison with conventional thromboplastins J Clin Pathol. 50:1997;951-956.
14. Ansell J.E. Empowering patients to monitor and manage oral anticoagulation therapy. JAMA. 281:1999;182-183.
15. White R.H., McCurdy S.A., von Marsendorff H., Woodruff D.E.J., Leftgoff L. Home prothrombin time monitoring after the initiation of warfarin therapy: a randomized, prospective study. Ann Intern Med. 111:1989;730-737.
16. Bernardo A. Experience with patient self-management of oral anticoagulation. J Thromb Thrombolys. 2:1996;321-325.
17. Anderson D.R., Harrison L., Hirsh J. Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy. Arch Intern Med. 153:1993;1441-1447.
18. Ansell J.E., Patek N., Ostrovsky D., Nozzolillo E., Peterson A.M., Fish L. Long-term patient self-management of oral anticoagulation. Arch Intern Med. 155:1995;2185-2189.
19. Hasenkam J.M., Kimose H.H., Knudsen L.et al. Self management of oral anticoagulant therapy after heart valve replacement. Eur J Cardiothor Surg. 11:1997;935-942.
20. Horstkotte D., Piper C., Wiemer M., Schulte H.D., Schultheiss H.P. Improvement of prognosis by home prothrombin estimation in patients with life-long anticoagulant therapy. Eur Heart J. 17(suppl):1996;230.
21. Sawicki P.T. A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized control trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation. JAMA. 281:1999;145-150.
22. Morsdorf S., Erdlenbruch W., Taborski U.et al. Training of patients for self-management of oral anticoagulant therapy. standards, patient suitability, and clinical aspects Semin Thromb Hemost. 25:1999;109-116.
23. Van den Besselaar A.M.H.P., Breddin K., Lutze G.et al. Multicenter evaluation of a new capillary blood prothrombin time monitoring system. Blood Coagul Fibrinolys. 6:1995;726-732.
24. Douketic J.D., Lane A., Milne J., Ginsberg J.S. Accuracy of a portable International Normalization Ratio monitor in outpatients receiving long-term oral anticoagulant therapy. comparison with a laboratory reference standard using clinically relevant criteria for agreement Thromb Res. 92:1998;11-17.
25. Todd C., Bradley C. Evaluating the design and development of psychological scales. Bradley C. Handbook of psychology and diabetes: a guide to psychological measurement in diabetes research and practice. 1994;15-42 Harwood Academic Publishers, Newark, NJ.
26. Bland J.M., Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. ii:1986;307-310.
27. Kramer M.S., Feinstein A.R. Clinical biostatistics. LIV - the biostatistics of concordance Clin Pharmacol Ther. 29:1981;111-123.
28. Azar A.J., Deckers J.W., Rosendaal F.R.et al. Assessment of therapeutic quality control in a long-term anticoagulant trial in post-myocardial infarction patients. Thromb Haemost. 72:1994;347-351.
29. Levine M.N., Roaskob G., Landefeld S., Kearon C. Haemorrhagic complications of anticoagulant treatment. Chest. 114:1998;511S-523S.
30. Landefeld C.S., Beyth R.J. Anticoagulant-related bleeding. Clinical epidemiology, prediction, and prevention Am J Med. 95:1993;315-328.
31. van der Meer J.F., Rosedaal F.R., Vandenbroucke J.P., Briet E. Bleeding complications in oral anticoagulant therapy. An analysis of risk factors. Arch Intern Med. 153:1993;1557-1562.
32. van der Meer F.J., Briet E., Vandenbroucke J.P., Stramek D.I., Versuijs M.H., Rosendaal F.R. The role of compliance as a cause of instability in oral anticoagulant therapy. Br J Haematol. 98:1997;893-900.
33. Kaatz SS, White RH, Hill J, Mascha E, Humphries JE, Becker DM. Accuracy of laboratory and portable monitor international normalized ratio determinations. Comparison with a criterion standard. Arch Intern Med 155: 1861-67.
34. Kok G., van den Borne B., Mullen P.D. Effectiveness of health education and health promotion: meta-analysesof effect studies and determinants of effectiveness. Pat Educat Couns. 30:1997;19-27.
35. Taborski U., Wittstamm F.J., Bernardo A. Cost-effectiveness of self-managed anticoagulant therapy in Germany. Semin Thromb Hemost. 25:1999;103-108.